These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26358784)

  • 21. Activity cliff networks for medicinal chemistry.
    Stumpfe D; Bajorath J
    Drug Dev Res; 2014 Aug; 75(5):291-8. PubMed ID: 25160069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of three-dimensional activity cliffs formed by kinase inhibitors with different binding modes and cliff mapping of structural analogues.
    Furtmann N; Hu Y; Bajorath J
    J Med Chem; 2015 Jan; 58(1):252-64. PubMed ID: 25054653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of occurrence and potency range distribution of activity cliffs in bioactive compounds.
    Stumpfe D; Bajorath J
    J Chem Inf Model; 2012 Sep; 52(9):2348-53. PubMed ID: 22866827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methods for computer-aided chemical biology. Part 3: analysis of structure-selectivity relationships through single- or dual-step selectivity searching and Bayesian classification.
    Stumpfe D; Geppert H; Bajorath J
    Chem Biol Drug Des; 2008 Jun; 71(6):518-28. PubMed ID: 18482335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extending the activity cliff concept: structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database.
    Hu Y; Bajorath J
    J Chem Inf Model; 2012 Jul; 52(7):1806-11. PubMed ID: 22758389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of multitarget activity landscapes that capture hierarchical activity cliff distributions.
    Dimova D; Wawer M; Wassermann AM; Bajorath J
    J Chem Inf Model; 2011 Feb; 51(2):258-66. PubMed ID: 21275393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extraction of SAR information from activity cliff clusters via matching molecular series.
    Dimova D; Bajorath J
    Eur J Med Chem; 2014 Nov; 87():454-60. PubMed ID: 25282268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic identification of scaffolds representing compounds active against individual targets and single or multiple target families.
    Hu Y; Bajorath J
    J Chem Inf Model; 2013 Feb; 53(2):312-26. PubMed ID: 23339619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods for computer-aided chemical biology. Part 1: Design of a benchmark system for the evaluation of compound selectivity.
    Stumpfe D; Ahmed HE; Vogt I; Bajorath J
    Chem Biol Drug Des; 2007 Sep; 70(3):182-94. PubMed ID: 17718713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of individual compounds forming activity cliffs using emerging chemical patterns.
    Namasivayam V; Iyer P; Bajorath J
    J Chem Inf Model; 2013 Dec; 53(12):3131-9. PubMed ID: 24304008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyzing Promiscuity at the Level of Active Compounds and Targets.
    Bajorath J
    Mol Inform; 2016 Dec; 35(11-12):583-587. PubMed ID: 27870240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of activity cliffs using support vector machines.
    Heikamp K; Hu X; Yan A; Bajorath J
    J Chem Inf Model; 2012 Sep; 52(9):2354-65. PubMed ID: 22894655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scanning structure-activity relationships with structure-activity similarity and related maps: from consensus activity cliffs to selectivity switches.
    Medina-Franco JL
    J Chem Inf Model; 2012 Oct; 52(10):2485-93. PubMed ID: 22989212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From activity cliffs to activity ridges: informative data structures for SAR analysis.
    Vogt M; Huang Y; Bajorath J
    J Chem Inf Model; 2011 Aug; 51(8):1848-56. PubMed ID: 21761918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic identification and classification of three-dimensional activity cliffs.
    Hu Y; Furtmann N; Gütschow M; Bajorath J
    J Chem Inf Model; 2012 Jun; 52(6):1490-8. PubMed ID: 22612566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large-scale assessment of activity landscape feature probabilities of bioactive compounds.
    Kayastha S; Dimova D; Iyer P; Vogt M; Bajorath J
    J Chem Inf Model; 2014 Feb; 54(2):442-50. PubMed ID: 24410456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Promiscuity Cliffs Using Machine Learning.
    Blaschke T; Feldmann C; Bajorath J
    Mol Inform; 2021 Jan; 40(1):e2000196. PubMed ID: 32881355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring global growth of activity cliff information over time and assessing activity cliff frequencies and distributions.
    Stumpfe D; Bajorath J
    Future Med Chem; 2015 Aug; 7(12):1565-79. PubMed ID: 26334207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring SAR continuity in the vicinity of activity cliffs.
    Namasivayam V; Iyer P; Bajorath J
    Chem Biol Drug Des; 2012 Jan; 79(1):22-9. PubMed ID: 21985661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Many drugs contain unique scaffolds with varying structural relationships to scaffolds of currently available bioactive compounds.
    Hu Y; Bajorath J
    Eur J Med Chem; 2014 Apr; 76():427-34. PubMed ID: 24602788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.